Racura Oncology receives approval for RC220 trial to proceed to higher dose

Blue Lake Biotechnology reports interim data from Phase 1/2a paediatric clinical trial of BLB201

ArkBio reports FDA clearance of IND application for AK0406

Enodia Therapeutics partners with Pfizer on Sec61-targeting drug development

TWINBIRD launches portable freezer targeting dry-ice-free research cold chains

Solvonis signs Portugal agreement to assess European expansion of Phase 3 alcohol addiction trial

Bristol Myers Squibb reports positive Phase 3 results for RYZ101 in neuroendocrine tumours

Bristol Myers Squibb reports positive Phase 3 results for admilparant in idiopathic pulmonary fibrosis

Camurus receives Canadian approval for Oczyesa XR for acromegaly

Perceptive Discovery partners with Nucleus RadioPharma Inc to accelerate radiopharmaceutical development

Akeso reports first patient dosed in Phase III study of cadonilimab in colon cancer

Glaukos reports positive Phase 4 results for iDose TR with cataract surgery

Medincell partner Teva secures FDA approval for monthly schizophrenia treatment

Alumis reports new Phase 3 data showing sustained skin clearance with envudeucitinib

FDA approves Genentech's Tecentriq combination therapy for stage III colon cancer